Sporadic Creutzfeldt-Jakob disease causing a 2-years slowly progressive isolated dementia

Alvaro Machado1, Manuel Ribeiro, Margarida Rodrigues

  • 1Neurology Department, Hospital de São Marcos, Largo Carlos Amarante, Braga, Portugal. alvmac@gmail.com

Behavioural Neurology
|December 10, 2009
PubMed

Insights

This case highlights a rare prion disease presenting solely as slowly progressive dementia. Diffusion-weighted MRI was crucial for diagnosis, revealing characteristic cortical lesions.

Area of Science:

  • Neurology
  • Neuroscience
  • Pathology

Background:

  • Prion diseases are a group of fatal neurodegenerative disorders characterized by progressive neurological decline.
  • Typical clinical presentations include rapidly progressive dementia, ataxia, and myoclonus, often with characteristic EEG findings.

Observation:

  • A 47-year-old woman presented with a 1-year history of progressive behavioral and cognitive disturbances, with moderate to severe cortical dysfunction.
  • Initial investigations, including EEG and CSF analysis, were unremarkable. MRI revealed ribbon-like cortical hyperintensities on diffusion-weighted imaging.
  • At 24 months, cognitive decline persisted with no ataxia or involuntary movements. MRI showed widespread cortical and new caudate-putamen hyperintensities. EEG remained non-specific.

Findings:

  • Stereotactic brain biopsy demonstrated spongiform changes, astrocytosis, and prion protein deposition.
  • Western blot analysis confirmed a prion type 2 mobility pattern.
  • Genetic analysis revealed heterozygosity at codon 129.

Implications:

  • This case underscores the diagnostic challenge of prion diseases presenting with dementia as the sole initial symptom.
  • The slow evolution over two years and lack of typical features initially suggested a primary degenerative dementia.
  • Diffusion-weighted MRI findings were pivotal in suspecting prion disease, guiding further diagnostic steps and biopsy.
  • This case expands the clinical spectrum of prion diseases, emphasizing the importance of advanced neuroimaging in atypical presentations.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.